Endometrial cancer patients' preferences for follow-up after treatment: A cross-sectional survey.


Journal

European journal of oncology nursing : the official journal of European Oncology Nursing Society
ISSN: 1532-2122
Titre abrégé: Eur J Oncol Nurs
Pays: Scotland
ID NLM: 100885136

Informations de publication

Date de publication:
Apr 2020
Historique:
received: 25 09 2019
revised: 03 01 2020
accepted: 13 01 2020
pubmed: 6 2 2020
medline: 29 9 2020
entrez: 5 2 2020
Statut: ppublish

Résumé

Alternatives to hospital follow-up (HFU) following treatment for cancer have been advocated. Telephone follow-up (TFU) and patient-initiated follow-up are being implemented but it is unclear if these approaches will meet the preferences and needs of patients. This study aimed to explore the preferences of endometrial cancer patients and their levels of satisfaction with HFU and nurse-led TFU. A cross-sectional survey design was utilised and a questionnaire was administered to 236 patients who had participated in a randomised controlled trial comparing HFU with TFU for women diagnosed with Stage I endometrial cancer (ENDCAT trial). 211 (89.4%) patients returned the questionnaire; 105 in the TFU group and 106 in the HFU group. The TFU group were more likely to indicate that appointments were on time (p < 0.001) and were more likely to report that their appointments were thorough (p = 0.011). Participants tended to prefer what was familiar to them. Those in the HFU group tended to prefer hospital-based appointments while the TFU group tended to prefer appointments with a clinical nurse specialist, regardless of locality. To provide patient centred follow-up services we need to ensure that patient preferences are taken into account and understand that patients may come to prefer what they have experienced. Patient initiated approaches may become standard and preferred practice but TFU remains a high-quality alternative to HFU and may provide an effective transition between HFU and patient-initiated approaches.

Identifiants

pubmed: 32014709
pii: S1462-3889(20)30002-8
doi: 10.1016/j.ejon.2020.101722
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

101722

Subventions

Organisme : Department of Health
ID : PB-PG-0610-22123
Pays : United Kingdom

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest None declared.

Auteurs

Kinta Beaver (K)

School of Sport & Health Sciences, Faculty of Health & Wellbeing, Brook Building, University of Central Lancashire, Preston, Lancashire, PR1 2HE, United Kingdom. Electronic address: kbeaver@uclan.ac.uk.

Susan Williamson (S)

School of Sport & Health Sciences, Faculty of Health & Wellbeing, Brook Building, University of Central Lancashire, Preston, Lancashire, PR1 2HE, United Kingdom. Electronic address: swilliamson2@uclan.ac.uk.

Chris J Sutton (CJ)

Centre for Biostatistics, School of Health Sciences, Faculty of Biology, Medicine and Health, Jean McFarlane Building, The University of Manchester, Oxford Road, Manchester, M13 9PL, United Kingdom. Electronic address: Christopher.J.Sutton@manchester.ac.uk.

Anne Gardner (A)

Women's Health Research Department, Lancashire Teaching Hospitals NHS Foundation Trust, Royal Preston Hospital, Sharoe Green Lane, Fulwood, Preston, Lancashire, PR2 9HT, United Kingdom. Electronic address: Anne.Gardner@lthtr.nhs.uk.

Pierre Martin-Hirsch (P)

Department of Obstetrics & Gynaecology, Lancashire Teaching Hospitals NHS Foundation Trust, Royal Preston Hospital, Sharoe Green Lane, Fulwood, Preston, Lancashire, PR2 9HT, United Kingdom. Electronic address: martin.hirsch@mac.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH